Priyanka Parte Selected Research

alpha-hydroxytamoxifen

10/2005

Oxidation of tamoxifen by human flavin-containing monooxygenase (FMO) 1 and FMO3 to tamoxifen-N-oxide and its novel reduction back to tamoxifen by human cytochromes P450 and hemoglobin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Priyanka Parte Research Topics

Disease

2	Asthenozoospermia 01/2019 - 01/2014
1	Neoplasms (Cancer) 01/2019
1	Osteoporosis 01/2015
1	Metabolic Bone Diseases (Osteopenia) 01/2015
1	Embryo Loss 05/2009
1	Breast Neoplasms (Breast Cancer) 10/2005

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2015
2	Tamoxifen FDA LinkGeneric 05/2009 - 10/2005
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2019
1	Actins (F Actin)IBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2014
1	TubulinIBA 01/2014
1	Insulin-Like PeptidesIBA 05/2009
1	tamoxifen N-oxideIBA 10/2005
1	N-desmethyltamoxifenIBA 10/2005
1	afimoxifene (hydroxytamoxifen)IBA 10/2005
1	alpha-hydroxytamoxifenIBA 10/2005

Therapy/Procedure

1	Therapeutics 10/2005